MOLOGEN AG / Key word(s): Capital Increase 10.07.2012 08:25 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- MOLOGEN AG capital increase: Proceeds of 22 million EUR As part of the current capital increase MOLOGEN AG has achieved gross proceeds of 22 million EUR. Overall, 2,589,819 new shares have been placed at an issue price of 8.50 EUR. Existing investors contributed in a significant amount to the capital increase. In addition, subscriptions for shares by national and international institutional investors supplemented the order book. The funds are to be primarily used for further expansion of the product pipeline. The Management and Supervisory Board of the company will file the implementation of the capital increase for entry in the German Commercial Register immediately. The delivery of the new shares is expected to take place one banking day after the admission of the new shares to trading on the Regulated Market of the Frankfurt Stock Exchange with additional post-admission obligations (Prime Standard), i.e. on July 16, 2012. The quirin bank AG was responsible for overseeing the capital increase. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: 'With the proceeds raised, we are able to further expand our product pipeline as planned. In addition, the financial basis of MOLOGEN AG has been strengthened substantially thus improving our position in the negotiation process for the out-licensing of MGN1703 considerably', said Dr. Matthias Schroff, Chief Executive Officer of MOLOGEN AG. 10.07.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: MOLOGEN AG FabeckstraÃe 30 14195 Berlin Germany Phone: 030 / 841788-0 Fax: 030 / 841788-50 E-mail: info@mologen.com Internet: www.mologen.com ISIN: DE0006637200 WKN: 663720 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: MOLOGEN AG capital increase: Proceeds of 22 million EUR
| Source: EQS Group AG